Retrovirus-based manufacturing of chimeric antigen receptor-modified T cells for cancer therapy research.
Saved in:
| Title: | Retrovirus-based manufacturing of chimeric antigen receptor-modified T cells for cancer therapy research. |
|---|---|
| Authors: | Stock S; Division of Clinical Pharmacology, Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany; Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich, A Partnership Between the DKFZ Heidelberg and LMU University Hospital, Munich, Germany. Electronic address: sophia.stock@med.uni-muenchen.de., Fertig L; Division of Clinical Pharmacology, Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany., Menkhoff VD; Division of Clinical Pharmacology, Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany., Strzalkowski T; Division of Clinical Pharmacology, Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany., Caruso M; CHU de Québec-Université Laval Research Center (Oncology division), Université Laval Cancer Research Center, Québec, QC, Canada., Kobold S; Division of Clinical Pharmacology, Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich, A Partnership Between the DKFZ Heidelberg and LMU University Hospital, Munich, Germany; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany. Electronic address: sebastian.kobold@med.uni-muenchen.de. |
| Source: | Methods in cell biology [Methods Cell Biol] 2025; Vol. 191, pp. 329-352. Date of Electronic Publication: 2024 Nov 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Academic Press Country of Publication: United States NLM ID: 0373334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0091-679X (Print) Linking ISSN: 0091679X NLM ISO Abbreviation: Methods Cell Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39824562 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Retrovirus-based manufacturing of chimeric antigen receptor-modified T cells for cancer therapy research. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Stock+S%22">Stock S</searchLink>; Division of Clinical Pharmacology, Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany; Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich, A Partnership Between the DKFZ Heidelberg and LMU University Hospital, Munich, Germany. Electronic address: sophia.stock@med.uni-muenchen.de.<br /><searchLink fieldCode="AU" term="%22Fertig+L%22">Fertig L</searchLink>; Division of Clinical Pharmacology, Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Menkhoff+VD%22">Menkhoff VD</searchLink>; Division of Clinical Pharmacology, Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Strzalkowski+T%22">Strzalkowski T</searchLink>; Division of Clinical Pharmacology, Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Caruso+M%22">Caruso M</searchLink>; CHU de Québec-Université Laval Research Center (Oncology division), Université Laval Cancer Research Center, Québec, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Kobold+S%22">Kobold S</searchLink>; Division of Clinical Pharmacology, Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich, A Partnership Between the DKFZ Heidelberg and LMU University Hospital, Munich, Germany; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany. Electronic address: sebastian.kobold@med.uni-muenchen.de. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220373334%22">Methods in cell biology</searchLink> [Methods Cell Biol] 2025; Vol. 191, pp. 329-352. <i>Date of Electronic Publication: </i>2024 Nov 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Academic+Press%22">Academic Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0373334 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>0091-679X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220091679X%22">0091679X </searchLink><i>NLM ISO Abbreviation: </i>Methods Cell Biol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39824562 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/bs.mcb.2024.10.017 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 329 Titles: – TitleFull: Retrovirus-based manufacturing of chimeric antigen receptor-modified T cells for cancer therapy research. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Stock S – PersonEntity: Name: NameFull: Fertig L – PersonEntity: Name: NameFull: Menkhoff VD – PersonEntity: Name: NameFull: Strzalkowski T – PersonEntity: Name: NameFull: Caruso M – PersonEntity: Name: NameFull: Kobold S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 0091-679X Numbering: – Type: volume Value: 191 Titles: – TitleFull: Methods in cell biology Type: main |
| ResultId | 1 |
